"MYELOKATHEXIS"--A NEW FORM OF CHRONIC GRANULOCYTOPENIA. REPORT OF A CASE.

No abstract is available for this paper.

• Publication year

  1964

• Venue

  New England Journal of Medicine

• Publication date

  1964-04-02

• Fields of study

  Medicine

• Identifiers
  DOI 10.1056/NEJM196404022701402PMID 14101065
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CHRONIC GRANULOCYTOPENIA IN CHILDHOOD.

  1964cited by this paper
• Study of leukopenias and thrombocytopenias by the direct antiglobulin consumption test on leukocytes and/or platelets.

  1961cited by this paper
• The Mixed Antiglobulin Reaction in the Detection of Human Iso‐Antibodies against Leucocytes, Platelets and HeLa Cells

  1959cited by this paper
• The dead leukocyte content of the blood in normal and leukemic patients.

  1957cited by this paper
• A histochemical procedure for localizing and evaluating leukocyte alkaline phosphatase activity in smears of blood and marrow.

  1955cited by this paper
• A METHOD OF STUDYING LEUKOCYTIC FUNCTIONS IN VIVO

  1955cited by this paper

• WHIM syndrome in a child without the classic tetrad: a case confirmed by de novo CXCR4 mutation

  2026cites this paper
• Mavorixafor, CXCR4 antagonist, a novel treatment for WHIM syndrome, first FDA approval 2024

  2025cites this paper
• WHIM syndrome: from mechanism to targeted therapy - advances shaping clinical care.

  2025cites this paper
• CXCR2 deficiency with myelokathexis caused by a novel variant: correction via CRISPR/Cas9

  2025cites this paper
• Clinicopathologic features and the spectrum of myelokathexis in WHIM syndrome.

  2025cites this paper
• Unexpected diagnosis of WHIM syndrome in refractory autoimmune cytopenia

  2024cites this paper
• CXCR4 WHIM syndrome is a cancer predisposition condition for virus‐induced malignancies

  2024cites this paper
• Chromothripsis: an emerging crossroad from aberrant mitosis to therapeutic opportunities

  2024cites this paper
• Expanding CXCR4 variant landscape in WHIM syndrome: integrating clinical and functional data for variant interpretation

  2024cites this paper
• Use of plerixafor for short‐term management of leukopenia in a pediatric patient with WHIM syndrome

  2024cites this paper
• Mavorixafor: a new hope for WHIM syndrome.

  2024cites this paper
• CXCR4: from B-cell development to B cell–mediated diseases

  2024cites this paper
• Heterogeneous phenotype of a Chinese Familial WHIM syndrome with CXCR4V340fs gain-of-function mutation

  2024cites this paper
• A phase III randomized crossover trial of plerixafor versus G-CSF for treatment of WHIM syndrome

  2023cites this paper
• Reduced G protein signaling despite impaired internalization and β-arrestin recruitment in patients carrying a CXCR4Leu317fsX3 mutation causing WHIM syndrome

  2023cites this paper
• WHIM Syndrome: First Reported Case in a Patient of African Ancestry

  2023cites this paper
• Genetics of severe congenital neutropenia as a gateway to personalized therapy.

  2022cites this paper
• Case Report: A Novel CXCR4 Mutation in a Chinese Child With Kawasaki Disease Causing WHIM Syndrome

  2022cites this paper
• WHIM-синдром: обзор литературы и описание двух собственных клинических наблюдений в одной семье

  2022cites this paper
• Disease Progression of WHIM Syndrome in an International Cohort of 66 Pediatric and Adult Patients

  2022cites this paper
• The negative charge of the 343 site is essential for maintaining physiological functions of CXCR4

  2021cites this paper
• Характеристика группы пациентов с WHIM-синдромом

  2021cites this paper
• Characteristics of a group of patients with WHIM syndrome

  2021cites this paper
• Defects in Innate Immunity: Receptors and Signaling Components

  2021cites this paper
• The G Protein-Coupled Receptor Kinases (GRKs) in Chemokine Receptor-Mediated Immune Cell Migration: From Molecular Cues to Physiopathology

  2021cites this paper
• Primary Immunodeficiencies With Defects in Innate Immunity: Focus on Orofacial Manifestations

  2020cites this paper
• Morphology As a Guide to the Diagnosis of a Rare Cause of Neutropenia

  2020cites this paper
• CXCR4 antagonist AMD3100 (plerixafor): from an impurity to a therapeutic agent.

  2020cites this paper
• Warts, Hypogammaglobulinemia, Infections, Myelokathexis (WHIM) Syndrome

  2020cites this paper
• Aberrant CXCR4 Signaling at Crossroad of WHIM Syndrome and Waldenstrom’s Macroglobulinemia

  2020cites this paper
• Results of a Phase 2 Trial of an Oral CXCR4 Antagonist Mavorixafor for Treatment of WHIM Syndrome.

  2020cites this paper
• Low-level Cxcr4-haploinsufficient HSC engraftment is sufficient to correct leukopenia in WHIM syndrome mice.

  2019cites this paper
• Family studies of warts, hypogammaglobulinemia, immunodeficiency, myelokathexis syndrome.

  2019cites this paper
• Long-Term Outcome of WHIM Syndrome in 18 Patients: High Risk of Lung Disease and HPV-Related Malignancies.

  2019cites this paper
• Mozobil® (Plerixafor, AMD3100), 10 years after its approval by the US Food and Drug Administration

  2019cites this paper
• Primary immunodeficiencies reveal the essential role of tissue neutrophils in periodontitis

  2019cites this paper
• WHIM Syndrome: from Pathogenesis Towards Personalized Medicine and Cure

  2019cites this paper
• A case report of a congenital immune deficiency disease –WHIM syndrome

  2019cites this paper
• Multisystem multitasking by CXCL12 and its receptors CXCR4 and ACKR3

  2018cites this paper
• WHIM syndrome: Immunopathogenesis, treatment and cure strategies

  2018cites this paper
• Adaptive Immunodeficiency in WHIM Syndrome

  2018cites this paper
• Harnessing CXCR4 antagonists in stem cell mobilization, HIV infection, ischemic diseases, and oncology

  2018cites this paper
• How I treat warts, hypogammaglobulinemia, infections, and myelokathexis syndrome.

  2017cites this paper
• Pathogenesis, diagnosis and therapeutic strategies in WHIM syndrome immunodeficiency

  2017influential citation
• Mechanisms of Sustained Neutrophilia in Patient WHIM-09, Cured of WHIM Syndrome by Chromothripsis

  2017cites this paper
• Defects in Intrinsic and Innate Immunity: Receptors and Signaling Components

  2017cites this paper
• Non-Neoplastic Morphologic Abnormalities of White Blood Cells and Macrophages

  2017cites this paper
• WHIM Syndrome Caused by Waldenström’s Macroglobulinemia-Associated Mutation CXCR4L329fs

  2016cites this paper
• CXCR4 signaling in health and disease.

  2016cites this paper
• Functional analysis of epithelium-specific Ets transcription factor-1 in inflammation

  2016cites this paper
• Chromothriptic cure of WHIM syndrome.

  2015influential citation
• Primary immunodeficiency update: Part II. Syndromes associated with mucocutaneous candidiasis and noninfectious cutaneous manifestations.

  2015cites this paper
• The duality of chemokines in heart failure

  2015cites this paper
• Human Immunodeficiencies Related to Defective APC/T Cell Interaction

  2015cites this paper
• Primary immunodeficiency update: Part I. Syndromes associated with eczematous dermatitis.

  2015cites this paper
• Chromothriptic cure of WHIM syndrome: Implications for bone marrow transplantation

  2015cites this paper
• Disorders of the Innate Host Defenses

  2015cites this paper
• Inhibitors of CXC chemokine receptor type 4: putative therapeutic approaches in inflammatory diseases

  2014cites this paper
• Innate immune cell migration and function in response to damage associated signals

  2014cites this paper
• Diagnostic assays for chronic granulomatous disease and other neutrophil disorders.

  2014cites this paper
• Genetics on a WHIM

  2014cites this paper
• Warts, Hypogammaglobulinemia, Infections, and Myelokathexis Syndrome

  2014cites this paper
• A phase 1 clinical trial of long-term, low-dose treatment of WHIM syndrome with the CXCR4 antagonist plerixafor.

  2014cites this paper
• [WHIM syndrome: presumptive diagnosis based on myelokathexis on bone marrow smear].

  2014cites this paper
• How we evaluate and treat neutropenia in adults.

  2014cites this paper
• Impact d’un gain de fonction de Cxcr4 sur le développement et la compartimentalisation périphérique des lymphocytes

  2013cites this paper
• On a WHIM.

  2013cites this paper
• Pathogenic mechanisms and clinical implications of congenital neutropenia syndromes

  2013cites this paper
• precursors by accelerated apoptosis and defective expression ofbcl-x in neutrophil Myelokathexis, a congenital disorder of severe neutropenia characterized

  2013cites this paper
• Alteration in blood leukocyte profile due to exercise and its implication

  2013cites this paper
• Hypogammaglobulinemia, Infections, Myelokathexis (WHIM) syndrome Altered leukocyte response to CXCL12 in patients with Warts

  2013cites this paper
• Leukocyte migration from a fish eye's view

  2012cites this paper
• Generalized verrucosis: a review of the associated diseases, evaluation, and treatments.

  2012cites this paper
• Distinct signalling mechanisms mediate neutrophil attraction to bacterial infection and tissue injury

  2012cites this paper
• Tetralogy of Fallot is an Uncommon Manifestation of Warts, Hypogammaglobulinemia, Infections, and Myelokathexis Syndrome

  2012cites this paper
• Warts and all: human papillomavirus in primary immunodeficiencies.

  2012cites this paper
• Description and outcome of a cohort of 8 patients with WHIM syndrome from the French Severe Chronic Neutropenia Registry

  2012cites this paper
• with WHIM syndrome The CXCR4 antagonist plerixafor corrects panleukopenia in patients

  2012cites this paper
• CXCR4 as a Therapeutic Target

  2011cites this paper
• Congenital neutropenia: diagnosis, molecular bases and patient management

  2011cites this paper
• Clinical and genetic features of Warts, Hypogammaglobulinemia, Infections and Myelokathexis (WHIM) syndrome.

  2011cites this paper
• Genetic Basis of Inherited Bone Marrow Failure Syndromes

  2011influential citation
• The CXCR4 antagonist plerixafor corrects panleukopenia in patients with WHIM syndrome.

  2011cites this paper
• Oral Health Status In Children Undergoing Treatment For Neuropenia

  2011cites this paper
• The CXCR4 antagonist plerixafor is a potential therapy for myelokathexis, WHIM syndrome.

  2011cites this paper
• Released on a WHIM.

  2011cites this paper
• A report of WHIM syndrome (myelokathexis) - clinical features and bone marrow morphology

  2011cites this paper
• Dual roles for Rac2 in neutrophil motility and active retention in zebrafish hematopoietic tissue.

  2011cites this paper
• Stromal-Derived Factor-1/CXCR4 Signaling: Indispensable Role in Homing and Engraftment of Hematopoietic Stem Cells in Bone Marrow

  2011cites this paper
• Th1 and Th17 join forces for acute GVHD.

  2011cites this paper
• [Dysfunctions of the CXCL12 (SDF-1)/CXCR4 signaling axis in the WHIM syndrome and the idiopathic CD4(+) T-cell lymphocytopenia].

  2010cites this paper
• CXCL12/CXCR4-Axis Dysfunctions: Markers of the Rare Immunodeficiency Disorder WHIM Syndrome

  2010cites this paper
• Severe congenital neutropenia in a multigenerational family with a novel neutrophil elastase (ELANE) mutation

  2010cites this paper
• CXCR2 and CXCR4 antagonistically regulate neutrophil trafficking from murine bone marrow.

  2010cites this paper
• WHIM syndrome and oral squamous cell carcinoma.

  2010cites this paper
• Neutrophil kinetics in health and disease

  2010cites this paper
• Emberger syndrome—Primary lymphedema with myelodysplasia: Report of seven new cases

  2010cites this paper
• A quadrivalent HPV vaccine induces humoral and cellular immune responses in WHIM immunodeficiency syndrome.

  2010cites this paper
• Genetic Insights into Congenital Neutropenia

  2010cites this paper
• Potential large animal models for gene therapy of human genetic diseases of immune and blood cell systems.

  2009cites this paper